Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) FCF Payout Ratio: 2020-2024

Historic FCF Payout Ratio for Maravai Lifesciences Holdings (MRVI) over the last 3 years, with Dec 2024 value amounting to 0.00.

  • Maravai Lifesciences Holdings' FCF Payout Ratio was N/A to 0.00 in Q4 2024 from the same period last year, while for Dec 2024 it was -0.46, marking a year-over-year change of. This contributed to the annual value of -0.02 for FY2024, which is 114.06% down from last year.
  • Maravai Lifesciences Holdings' FCF Payout Ratio amounted to 0.00 in Q4 2024, which was down 94.75% from 0.07 recorded in Q2 2024.
  • Maravai Lifesciences Holdings' 5-year FCF Payout Ratio high stood at 1.70 for Q4 2020, and its period low was -0.22 during Q2 2023.
  • Its 3-year average for FCF Payout Ratio is 0.15, with a median of 0.18 in 2022.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' FCF Payout Ratio soared by 16,184.27% in 2021 and then slumped by 184.96% in 2023.
  • Maravai Lifesciences Holdings' FCF Payout Ratio (Quarterly) stood at 1.70 in 2020, then plummeted by 47.62% to 0.89 in 2021, then slumped by 62.62% to 0.33 in 2022, then slumped by 184.96% to -0.22 in 2023, then skyrocketed by 132.62% to 0.00 in 2024.
  • Its FCF Payout Ratio stands at 0.00 for Q4 2024, versus 0.07 for Q2 2024 and -0.22 for Q2 2023.